Top Markets
Coin of the day
BrainsWay Ltd. BrainsWay Ltd.

BrainsWay Ltd.

BWAY
Rangering i aksjer #34049
Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally... Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.
Aksjekurs
$15.79
Sist synkronisert: 2026-08-14
Markedsverdi
$6.34M
Endring (1 dag)
-2.64%
Endring (1 år)
142.12%
Land
IL
Handel BrainsWay Ltd. (BWAY)

Kategori

P/B-forhold for BrainsWay Ltd. (BWAY)
P/B-forhold per 2026 TTM: 0
Ifølge BrainsWay Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for BrainsWay Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter